Vaniam Group is a people-first, purpose-driven, independent network of healthcare and scientific communications agencies committed to helping their clients and their people realize their full potential. Founded in 2007 as a 100% virtual-by-design organization, Vaniam Group is a WBENC-Certified Women’s Business Enterprise (WBE). The company's portfolio includes Bio Linx, Bio Connections, Nexus, Nexus Science, Team 9, Team 9 Science, Second City Insights, Second City Science, CurioScience, Bio Ascend, and Women Leaders in Oncology. Vaniam Group aspires to elevate the way people and clients think, work, and communicate within the oncology and hematology therapeutic marketplace. The company partners with biotech and pharmaceutical clients’ commercial, medical, and clinical teams to create and communicate a differentiated value proposition at the brand, franchise, and corporate level. By identifying and engaging the right external experts, their clients’ initiatives yield deep insights that in turn inform effective strategies and impactful communication of clinical science. One of the remarkable aspects of Vaniam Group is their virtual-by-design model, which not only allows the company to hire the best talent regardless of geography but also inspires them to redefine and unlock the possibilities of the 21st-century workplace. As a WBENC-Certified Women’s Business Enterprise, Vaniam Group is dedicated to fostering diversity and inclusivity in the workplace. Overall, Vaniam Group's commitment to being people-first and purpose-drivenmarketing sector. For potential venture capital investors looking to support a forward-thinking and innovative company in the healthcare and scientific communications space, Vaniam Group presents an opportunity to contribute to the advancement of this crucial industry.
There is no investment information
No recent news or press coverage available for Vaniam Group.